- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/26 - Radicals substituted by halogen atoms or nitro radicals
Patent holdings for IPC class C07D 213/26
Total number of patents in this class: 224
10-year publication summary
|
14
|
19
|
16
|
11
|
12
|
7
|
9
|
12
|
8
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dow AgroSciences LLC | 1223 |
9 |
| Novartis AG | 10726 |
7 |
| Mycovia Pharmaceuticals, Inc. | 41 |
6 |
| Merck Sharp & Dohme LLC | 3750 |
6 |
| Sumitomo Chemical Company, Limited | 9051 |
5 |
| UDC Ireland Limited | 474 |
5 |
| The Regents of the University of Michigan | 4733 |
4 |
| Essilor International (compagnie Generale D'optique) | 2990 |
4 |
| FMC Corporation | 841 |
4 |
| Osaka University | 3385 |
4 |
| Rigel Pharmaceuticals, Inc. | 538 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2866 |
4 |
| Agc, Inc. | 4901 |
4 |
| Corteva Agriscience LLC | 2691 |
4 |
| Bristol-myers Squibb Company | 4867 |
3 |
| Samsung Display Co., Ltd. | 35100 |
3 |
| Canon Inc. | 40280 |
3 |
| Daikin Industries, Ltd. | 10058 |
3 |
| BIAL - Portela & CA, S.A. | 224 |
3 |
| Nankai University | 236 |
3 |
| Other owners | 136 |